Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
Career developments of executives in the pharmaceutical industry are discussed. Jeremy Curnock Cook has been appointed to chairman of the board of directors at Inflazyme Pharmaceuticals Ltd. Dinu Sen has been named CEO of Avera Pharmaceuticals Inc., replacing founding president and CEO Jeffrey F. McKelvy. Mark Leuchtenberger has been named president and CEO of privately held anti-bacterial drug developer Targanta Therapeutics Inc.